Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy?

Publication date: Available online 28 October 2017
Source:Radiotherapy and Oncology
Author(s): Catharina T.G. Roos, Veerle A.B. van den Bogaard, Marcel J.W. Greuter, Rozemarijn Vliegenthart, Ewoud Schuit, Johannes A. Langendijk, Arjen van der Schaaf, Anne P.G. Crijns, John H. Maduro
Background and purposeThe main objective of this study was to test whether pre-treatment coronary artery calcium (CAC) was associated with the cumulative incidence of acute coronary events (ACE) among breast cancer (BC) patients treated with postoperative radiotherapy (RT).Material and methodsThe study population consisted of 939 consecutive female BC patients treated with RT. The association between CAC and ACE was tested using Cox-proportional hazard models. Known risk factors for ACE and the mean heart dose (MHD), collected from three-dimensional computed tomography planning data, were tested for confounding.ResultsCAC scores varied from 0 to 2,859 (mean 27.3). The 9-year cumulative incidence of ACE was 3.2%, this was significantly associated with the pre-treatment CAC score. After correction for confounders, age, history of ischemic heart disease, diabetes, Body Mass Index ≥30, MHD, hypercholesterolemia and hypertension, the hazard ratio for ACE for the low and the combined intermediate and high CAC score category were 1.42 (95%CI: 0.49–4.17; p = 0.519) and 4.95 (95%CI: 1.69–14.53; p = 0.004) respectively, compared to the CAC zero category.ConclusionsHigh pre-treatment CAC is associated with ACE in BC patients treated with postoperative RT, even after correction for confounding factors such as MHD.



http://ift.tt/2hlYTKs